ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

Interview With Screening Expert Barnett Kramer, PLCO Investigator

March 20, 2009

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

October 25, 1985

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979

New GAO Report Critical Of federal Effort Against Environmental Carcinogenesis

June 25, 1976

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

March 31, 2000